fbpx

November 18, 2019

News

Hope for Better Quality of Life for Tourette’s Patients

After trying a dozen different medications, Chris, a Brisbane man who was diagnosed with debilitating Tourette’s Syndrome at age 12, is part of an Australian-first medicinal cannabis trial. For the past 16 years, the condition has impacted all aspects of Chris’ life, including his mental health. This trial has offered Chris more than hope. It’s offered a future.

Read More »

Wesley Medical Research

Scroll to Top